<p><strong>聯合健康集團</strong> UNH 面臨新的法律壓力，股東們提起了額外的訴訟，其中許多訴訟提到《華爾街日報》在五月報道的對公司醫療保險賬單做法的聯邦調查。</p>
<h2><strong>最新訴訟的細節</strong></h2>
<p><strong>史蒂夫·西爾弗曼</strong>，自 2003 年以來的聯合健康股東，上週在明尼蘇達州的聯邦法院提起了一項派生訴訟。在派生訴訟中，股東代表公司對其領導層提出索賠，指控對公司本身造成損害。</p>
<p>西爾弗曼的投訴指控聯合健康的領導層，包括首席執行官 <strong>斯蒂芬·赫姆斯利</strong>、前首席執行官 <strong>安德魯·維蒂</strong> 及幾位董事會成員，存在以下行為：</p>
<ul>
<li>違反受託責任</li>
<li>從事內幕交易</li>
<li>不當得利</li>
<li>違反 1934 年證券交易法</li>
</ul>
<p>該訴訟提到多篇關於聯合健康賬單做法的媒體報道，這些報道最終導致《華爾街日報》的一篇文章揭示司法部正在準備對該保險公司的醫療保險業務進行刑事調查。</p>
<p>&#34;儘管多次警告，聯合健康對虛高編碼做法的依賴至少持續到 2023 年，並顯然延續到 2024 年，&#34;西爾弗曼的訴訟稱，依據保險新聞網的報道。</p>
<p>&#34;這些策略帶來了數十億美元的過度報銷，這一金額如此之大，以至於極大地誇大了公司的財務業績和股價，&#34;訴訟中指控稱。</p>
<p>聯合健康尚未對該訴訟發表評論。針對《華爾街日報》的報道，該公司表示尚未收到任何司法部調查的通知，併為其醫療保險優勢計劃的完整性辯護。</p>
<h2><strong>其他股東行動</strong></h2>
<p>其他投資者也提起了類似的訴訟：</p>
<ul>
<li>約瑟夫·克羅格納爾於 6 月 30 日提起投訴，指名與西爾弗曼相同的 14 名被告。</li>
<li>梅里·科古特於 6 月 14 日提起派生訴訟，指控聯合健康的領導層未能披露 2023 年底的勞動部調查。科古特聲稱，在此期間，公司以虛高價格回購了 73 億美元的股票，而高管們在司法部調查仍然保密時從股票銷售中獲利。</li>
</ul>
<p>科古特的訴訟指控赫姆斯利在司法部調查公開前從股票銷售中獲利 2.115 億美元，維蒂獲利 1100 萬美元。</p>
<p>這三起訴訟都集中在聯合健康的醫療保險賬單和報告做法上。原告認為，儘管公司的醫療保險業務非常盈利，但也吸引了負面關注，損害了其股價。</p>
<h2><strong>聯合健康動盪不安</strong></h2>
<p>聯合健康目前面臨一系列挑戰，包括這些訴訟、司法部調查、特朗普政府的監管變化以及最近的領導層動盪。</p>
<p>聯合健康首席執行官安德魯·維蒂於五月辭職，公司在發佈之前的盈利預測不到一個月後撤回了該預測。</p>
<p>此外，《華爾街日報》在週三發佈了一份新報告，稱前聯合健康員工告訴司法部調查人員，該公司在患者評估期間鼓勵捕捉某些有利可圖的診斷。</p>
<p>聯合健康集團定於 7 月 29 日公佈其第二季度財報和更新的指導意見。</p>
<p>根據 Benzinga Pro 的數據，UNH 股票年初至今已下跌超過 40%，在週三發佈時交易價格為 302.10 美元。</p>
<ul>
<li><strong>SoFi 準備在特朗普的 ‘大、美麗’ 計劃限制聯邦學生貸款時 ‘抓住機會’</strong></li>
</ul>
<p><em>照片：Shutterstock</em></p>

聯合健康

<p>聯合健康集團（UnitedHealth Group, Inc.）正面臨新的法律挑戰，因為股東們針對其醫療保險賬單做法提起了多起訴訟，這與聯邦調查有關。股東史蒂夫·西爾弗曼（Steve Silverman）提起的派生訴訟指控公司領導層違反信託責任和內幕交易，聲稱誇大的編碼做法導致了過高的報銷和顯著的股價膨脹。其他投資者也提起了類似的訴訟，強調對未披露調查和以高價回購股票的擔憂。在這些爭議和領導層變動的背景下，聯合健康的股票今年已暴跌超過 40%</p>

<p><strong>UnitedHealth Group, Inc.</strong> UNH is under renewed legal pressure as shareholders file additional lawsuits, many of which reference a federal investigation into the company's Medicare billing practices reported by the Wall Street Journal in May.</p>
<div class="lb-trans"><p><strong>聯合健康集團</strong> UNH 面臨新的法律壓力，股東們提起了額外的訴訟，其中許多訴訟提到《華爾街日報》在五月報道的對公司醫療保險賬單做法的聯邦調查。</p>
</div><h2><strong>Details of the Latest Lawsuit</strong></h2>
<div class="lb-trans"><h2><strong>最新訴訟的細節</strong></h2>
</div><p><strong>Steve Silverman</strong>, a UnitedHealth shareholder since 2003, filed a derivative lawsuit last week in federal court in Minnesota. In a derivative suit, a shareholder brings claims on behalf of the company against its own leadership, alleging harm to the corporation itself.</p>
<div class="lb-trans"><p><strong>史蒂夫·西爾弗曼</strong>，自 2003 年以來的聯合健康股東，上週在明尼蘇達州的聯邦法院提起了一項派生訴訟。在派生訴訟中，股東代表公司對其領導層提出索賠，指控對公司本身造成損害。</p>
</div><p>Silverman's complaint accuses UnitedHealth's leadership, including CEO <strong>Stephen Hemsley,</strong> former CEO <strong>Andrew Witty</strong> and several board members, of:</p>
<div class="lb-trans"><p>西爾弗曼的投訴指控聯合健康的領導層，包括首席執行官 <strong>斯蒂芬·赫姆斯利</strong>、前首席執行官 <strong>安德魯·維蒂</strong> 及幾位董事會成員，存在以下行為：</p>
</div><ul>
<li>Breaching their fiduciary duties</li>
<li>Engaging in insider trading</li>
<li>Unjust enrichment</li>
<li>Violating the Securities Exchange Act of 1934</li>
</ul>
<div class="lb-trans"><ul>
<li>違反受託責任</li>
<li>從事內幕交易</li>
<li>不當得利</li>
<li>違反 1934 年證券交易法</li>
</ul>
</div><p>The lawsuit references multiple media reports about UnitedHealth's billing practices, which culminated in the Wall Street Journal article that revealed the Department of Justice was preparing a criminal probe into the insurer's Medicare operations.</p>
<div class="lb-trans"><p>該訴訟提到多篇關於聯合健康賬單做法的媒體報道，這些報道最終導致《華爾街日報》的一篇文章揭示司法部正在準備對該保險公司的醫療保險業務進行刑事調查。</p>
</div><p>&#34;Despite repeated warnings, UnitedHealth's reliance on inflated coding practices continued through at least 2023 and apparently into 2024,&#34; Silverman's lawsuit claimed, according to Insurance Newsnet.</p>
<div class="lb-trans"><p>&#34;儘管多次警告，聯合健康對虛高編碼做法的依賴至少持續到 2023 年，並顯然延續到 2024 年，&#34;西爾弗曼的訴訟稱，依據保險新聞網的報道。</p>
</div><p>&#34;These tactics yielded billions of dollars in excessive reimbursements, a sum so large that it vastly inflated the Company's financial results and stock price,&#34; the lawsuit alleges.</p>
<div class="lb-trans"><p>&#34;這些策略帶來了數十億美元的過度報銷，這一金額如此之大，以至於極大地誇大了公司的財務業績和股價，&#34;訴訟中指控稱。</p>
</div><p>UnitedHealth has not commented on the lawsuit. In response to the Wall Street Journal's reporting, the company stated it had not been notified of any DOJ investigation and defended the integrity of its Medicare Advantage program.</p>
<div class="lb-trans"><p>聯合健康尚未對該訴訟發表評論。針對《華爾街日報》的報道，該公司表示尚未收到任何司法部調查的通知，併為其醫療保險優勢計劃的完整性辯護。</p>
</div><h2><strong>Additional Shareholder Actions</strong></h2>
<div class="lb-trans"><h2><strong>其他股東行動</strong></h2>
</div><p>Other investors have filed similar lawsuits:</p>
<div class="lb-trans"><p>其他投資者也提起了類似的訴訟：</p>
</div><ul>
<li>Joseph Crognale filed a complaint on June 30, naming the same 14 defendants as Silverman.</li>
<li>Merry Kogut filed a derivative suit on June 14, alleging that UnitedHealth's leadership failed to disclose a Department of Labor investigation in late 2023. Kogut claims the company repurchased $7.3 billion in stock at inflated prices during this period, and that executives profited from share sales while the DOJ probe was still secret.</li>
</ul>
<div class="lb-trans"><ul>
<li>約瑟夫·克羅格納爾於 6 月 30 日提起投訴，指名與西爾弗曼相同的 14 名被告。</li>
<li>梅里·科古特於 6 月 14 日提起派生訴訟，指控聯合健康的領導層未能披露 2023 年底的勞動部調查。科古特聲稱，在此期間，公司以虛高價格回購了 73 億美元的股票，而高管們在司法部調查仍然保密時從股票銷售中獲利。</li>
</ul>
</div><p>Kogut's lawsuit alleges that Hemsley made $211.5 million and Witty $11 million from stock sales before the DOJ investigation became public knowledge.</p>
<div class="lb-trans"><p>科古特的訴訟指控赫姆斯利在司法部調查公開前從股票銷售中獲利 2.115 億美元，維蒂獲利 1100 萬美元。</p>
</div><p>All three lawsuits center on UnitedHealth's Medicare billing and reporting practices. Plaintiffs argue that while the company's Medicare business has been highly profitable, it has also attracted negative attention that has hurt its stock price.</p>
<div class="lb-trans"><p>這三起訴訟都集中在聯合健康的醫療保險賬單和報告做法上。原告認為，儘管公司的醫療保險業務非常盈利，但也吸引了負面關注，損害了其股價。</p>
</div><h2><strong>UNH in Turmoil</strong></h2>
<div class="lb-trans"><h2><strong>聯合健康動盪不安</strong></h2>
</div><p>UnitedHealth is currently facing a series of challenges, including these lawsuits, a DOJ investigation, regulatory changes from the Trump administration and recent leadership upheaval.</p>
<div class="lb-trans"><p>聯合健康目前面臨一系列挑戰，包括這些訴訟、司法部調查、特朗普政府的監管變化以及最近的領導層動盪。</p>
</div><p>UnitedHealth CEO Andrew Witty resigned in May, and the company withdrew its previous earnings forecast less than a month after issuing it.</p>
<div class="lb-trans"><p>聯合健康首席執行官安德魯·維蒂於五月辭職，公司在發佈之前的盈利預測不到一個月後撤回了該預測。</p>
</div><p>Additionally, the Wall Street Journal released a new report on Wednesday, which claims that former UnitedHealth employees told DOJ investigators that the company encouraged the capture of certain lucrative diagnoses during patient assessments.</p>
<div class="lb-trans"><p>此外，《華爾街日報》在週三發佈了一份新報告，稱前聯合健康員工告訴司法部調查人員，該公司在患者評估期間鼓勵捕捉某些有利可圖的診斷。</p>
</div><p>UnitedHealth Group is set to report its second-quarter earnings and updated guidance on July 29.</p>
<div class="lb-trans"><p>聯合健康集團定於 7 月 29 日公佈其第二季度財報和更新的指導意見。</p>
</div><p>UNH shares have fallen more than 40% year-to-date, according to Benzinga Pro, and were trading at $302.10 at the time of publication on Wednesday.</p>
<div class="lb-trans"><p>根據 Benzinga Pro 的數據，UNH 股票年初至今已下跌超過 40%，在週三發佈時交易價格為 302.10 美元。</p>
</div><ul>
<li><strong>SoFi Ready To ‘Capture The Opportunity’ As Trump’s ‘Big, Beautiful’ Plan Restricts Federal Student Loans</strong></li>
</ul>
<div class="lb-trans"><ul>
<li><strong>SoFi 準備在特朗普的 ‘大、美麗’ 計劃限制聯邦學生貸款時 ‘抓住機會’</strong></li>
</ul>
</div><p><em>Photo: Shutterstock</em></p>
<div class="lb-trans"><p><em>照片：Shutterstock</em></p>
</div>

聯合健康因股票暴跌 1190 億美元再次面臨訴訟